![71DMjDEL1ZL._CLa|1283,1076|81MfEDAtTAL.jpg,81z8cpPFE0L.jpg|0,0,583,1076+700,0,583,1076+291,0,700,1076_._SY200_.jpg 71DMjDEL1ZL._CLa|1283,1076|81MfEDAtTAL.jpg,81z8cpPFE0L.jpg|0,0,583,1076+700,0,583,1076+291,0,700,1076_._SY200_.jpg](https://m.media-amazon.com/images/I/71DMjDEL1ZL._CLa%7C1283,1076%7C81MfEDAtTAL.jpg,81z8cpPFE0L.jpg%7C0,0,583,1076+700,0,583,1076+291,0,700,1076_._SY200_.jpg)
71DMjDEL1ZL._CLa|1283,1076|81MfEDAtTAL.jpg,81z8cpPFE0L.jpg|0,0,583,1076+700,0,583,1076+291,0,700,1076_._SY200_.jpg
![Discovery of a Novel Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) and Cyclin-Dependent Kinase 4 (CDK4) Dual Inhibitor for the Treatment of Triple-Negative Breast Cancer | Journal of Medicinal Chemistry Discovery of a Novel Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) and Cyclin-Dependent Kinase 4 (CDK4) Dual Inhibitor for the Treatment of Triple-Negative Breast Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00063/asset/images/large/jm2c00063_0008.jpeg)
Discovery of a Novel Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) and Cyclin-Dependent Kinase 4 (CDK4) Dual Inhibitor for the Treatment of Triple-Negative Breast Cancer | Journal of Medicinal Chemistry
![Discovery of a Novel Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) and Cyclin-Dependent Kinase 4 (CDK4) Dual Inhibitor for the Treatment of Triple-Negative Breast Cancer | Journal of Medicinal Chemistry Discovery of a Novel Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) and Cyclin-Dependent Kinase 4 (CDK4) Dual Inhibitor for the Treatment of Triple-Negative Breast Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00063/asset/images/medium/jm2c00063_0017.gif)